Real-World Incidence of Cancer Therapy-Related Cardiac Dysfunction in a Large, Diverse, and Contemporary Cohort [0.03%]
Samir R Thadani,Alan S Go,Jane Y Liu et al.
Samir R Thadani et al.
Aims: Cancer therapy-related cardiac dysfunction (CTRCD) is a significant complication of contemporary oncologic treatment and a key contributor to incident heart failure (HF) in cancer survivors. Although certain potenti...
Anne P Nelissen,Sander van Doorn,Carline J van den Dries et al.
Anne P Nelissen et al.
Aims: Little is known about the management and disease trajectories of heart failure (HF) patients in the pre-hospital setting when experiencing exacerbating symptoms. Shortness of breath (SOB) is a main reason for contac...
Evaluation and management of recent onset cardiomyopathy in the current era of heart failure therapeutics. A clinical consensus statement of the Heart Failure Association of the ESC [0.03%]
欧洲心脏学会心力衰竭协会临床共识声明：心血管医学当前治疗格局下近期发生的心肌病的评估与管理
Hadi Skouri,Amr Abdin,Wilfried Mullens et al.
Hadi Skouri et al.
Recent-onset cardiomyopathy represents a clinically dynamic and potentially reversible clinical framework of non-ischemic cardiomyopathy, characterized by high variability in left ventricular (LV) function and arrhythmic risk. This clinical...
Letter to the Editor on: Worse Long-Term Outcomes in New-Onset HFpEF vs HFrEF and HFmrEF: Findings from the Stockholm PREFERS Study [0.03%]
关于新发HFpEF远期结局恶化：斯德哥尔摩PREFERS研究结果的来信
Maria Giulia Bellicini
Maria Giulia Bellicini
Right ventricular free-wall strain-based risk stratification for temporary mechanical circulatory support in cardiogenic shock [0.03%]
右心室游离壁应变指导卡氏休克临时机械辅助治疗风险分层
Chong Bin Lee,Andreas Merz,Daniel-Armando Morris et al.
Chong Bin Lee et al.
Background: Early identification of patients with cardiogenic shock (CS) who will require temporary mechanical circulatory support (MCS) remains challenging. Right ventricular (RV) dysfunction is common in CS and affects ...
Impact of routine urine sodium evaluation on diuretic practices in patients with acute heart failure [0.03%]
常规评估尿钠对急性心力衰竭患者利尿剂使用的影响
Amitai Segev,Viana Copeland,David Mark Hochstein et al.
Amitai Segev et al.
Background and aims: Natriuresis-guided diuresis has been investigated in prospective trials for acute heart failure (HF), but its impact on diuretic prescribing in clinical practice is uncertain. ...
Use of sGC stimulators in heart failure therapy - a mode of action perspective [0.03%]
从作用模式角度谈sGC刺激剂在心力衰竭治疗中的应用
Frank Ruschitzka,Robert Lukowski,Stefano Corda et al.
Frank Ruschitzka et al.
Despite recent advances in pharmacological treatment, chronic heart failure (HF) is associated with significant morbidity and mortality, and further treatment options are needed. Intact nitric oxide (NO)-soluble guanylyl cyclase (sGC)-cycli...
The Quantitative Haemodynamic Effect of Levosimendan, Dobutamine and Milrinone in Heart Failure Patients: a Meta-Analysis [0.03%]
兰索拉唑、多巴胺和米力农在心力衰竭患者中的定量血流动力学效应的 meta 分析
Vincenzo Nuzzi,Cristina Madaudo,Paolo Manca et al.
Vincenzo Nuzzi et al.
Aims: Inotropic therapy is a cornerstone of medical treatment for patients with low-output heart failure (HF). We aimed to investigate the quantitative effect of specific inotropic drugs on invasive haemodynamics. ...
Inhibition of Adenosine Kinase Alleviates Hypertrophic Cardiomyopathy by Ameliorating Coronary Microvascular Dysfunction [0.03%]
腺苷激酶抑制通过改善冠状微血管功能缓解肥厚型心肌病
Fangfang Wan,Bingxuan Ma,Ziqiang Han et al.
Fangfang Wan et al.
Background: Hypertrophic cardiomyopathy (HCM) remains challenging with limited treatment options, the identification of novel therapeutic targets is urgently needed. ...
Worsening heart failure-based hierarchical endpoints beyond HF hospitalization: expert opinion paper [0.03%]
心力衰竭住院治疗之外的病情恶化的心力衰竭分层终点指标：专家意见稿
Agustín Fernández-Cisnal,Gema Miñana,Rafael de la Espriella et al.
Agustín Fernández-Cisnal et al.
The traditional, hospitalization-centric composite endpoint of cardiovascular (CV) death or time-to-first heart failure (HF) hospitalization is increasingly misaligned with contemporary HF care and, as evidence-based therapies lower event r...